A Day Up For CEL-SCI Corporation

CEL-SCI Corporation (CVM:NYSEMKT) soared at $24.4, a gain of 21.7%. On Wed, Apr 21, 2021, CVM:NYSEMKT touched a New 2-Week High of $20.05. The stock appeared on our News Catalysts scanner on Thu, Apr 15, 2021 at 04:32 PM in the 'BIOTECH' category. From Wed, Apr 07, 2021, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Wed, Jan 27, 2021 at $40.91 with a volume of 14M+, and its share price has been moving sideways in recent weeks.
About CEL-SCI Corporation (CVM:NYSEMKT)
CEL-SCI Corp is a biotechnology company. It is engaged in the research & development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system.
Top 10 Gainers:
- Ocugen, Inc. (OCGN:NASDAQ), 42.92%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 40.22%
- CDAK (CDAK:NASDAQ), 34.64%
- Teradata Corporation (TDC:NYSE), 26.63%
- AENZ (AENZ:NYSE), 25.64%
- UCL (UCL:NASDAQ), 23.07%
- XM (XM:NASDAQ), 22.71%
- CEL-SCI Corporation (CVM:NYSEMKT), 21.7%
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 21.63%
- Takung Art Co., Ltd. (TKAT:NYSEMKT), 17.86%